CINV

NSW medical cannabis trial to treat chemotherapy patients suffering nausea

NSW medical cannabis trial to treat chemotherapy patients suffering nausea

AUSTRALIAN BROADCASTING CORPORATION

The largest clinical trial of its kind, testing medicinal cannabis to treat chemotherapy patients suffering from nausea, has been announced by New South Wales Premier Mike Baird. About 330 patients are expected to take part in the clinical trial which will use a cannabis-derived tablet manufactured by Canadian company Tilray.

NSW Government announces third medical cannabis trial for chemotherapy

NSW Government announces third medical cannabis trial for chemotherapy

SYDNEY MORNING HERALD

A Canadian pharmaceutical company, Tilray, will supply the trial with specially-prepared tablets that contain marijuana extracts that maximise the drug's anti-nausea properties and minimise its psychoactive effects.